TY - CHAP M1 - Book, Section TI - MYASTHENIA GRAVIS AND OTHER DISEASES OF THE NEUROMUSCULAR JUNCTION A1 - Drachman, Daniel B. A1 - Amato, Anthony A. A2 - Hauser, Stephen L. A2 - Josephson, S. Andrew PY - 2018 T2 - Harrison's Neurology in Clinical Medicine, 4e AB - Myasthenia gravis (MG) is a neuromuscular disorder characterized by weakness and fatigability of skeletal muscles. The underlying defect is a decrease in the number of available acetylcholine receptors (AChRs) at neuromuscular junctions due to an antibody-mediated autoimmune attack. Treatment now available for MG is highly effective, although a specific cure has remained elusive. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - neurology.mhmedical.com/content.aspx?aid=1161369614 ER -